Chronic Lameness Flashcards
What are some chronic lameness conditions in the horse?
- Osteoarthritis (Join synovitis)
- Navicular Dx
- Chronic Laminits
What is the most common cause of lameness in horses?
Osteoarthritis
What factors to consider with OA?
- Use of horse
- OWner’s expectation
- Age
- Severity
- N° of joint affected
- Risk of lamainits
- Other systemic dx
- Owner’s financial situation
- Associated soft tisue damage
Consequences of OA?
detail what steroids to use when?
INTRA-ARTICULAE ADMIN
Side effects of Corticosteroids?
- Laminitis (BEWARE if suspicious of endocrine dx)
- Iatrogenic Joint infection (low incidence)
- Periarticular cellulitis (diffuse swelling, hot painful)
- Joint flare - aseptic synovitis
- Deleterious effects on cartilage (MPA)
- SLows healing of joint injury
Describe the use of NSAId for OA ?
- Analgesic - SMOAD
- Improves joint mobility
- Inhibition of COX (COX 2 esp inflammation)
- Side effects due to COX 1 inhibition -> Gi ulceration, RDCn renal but Therapeutic effects due to COX 2
What do we HAVE to keep in mind abotu using NSAIDs?
- Narrow safety margin
- Not for competition animals
describe Phenylbut use?
- Most commonly used
- Cost effective –
86p/sachet - Oral or IV
administration - 2.2 mg/kg PO BID
- NOT COX selective
What is the FEI Detection TIme for Phenylbut?
7 days
What other options for NSAIds?
- > Suxibotazone (more palatable)
-> Firocoxib IV or PO
- 3mg/kg SID loading dose then 1 mg/kg SID maintenance
- COX 2 selective!
- FEI detection 14 days
What topical NSAID?
Diclofenac Cream - topical application BID
- licensed in UK not US
(equivalent in UK for humans is voltarol)
What other management considerations for OA?
- Weight management → Diet
- Recommendations: restrict forage to 1.5% bodyweight +
balancer in feed - Housing and environment
- Nutraceuticals
-> Weak scientific evidence for in vivo efficacy
-> Lots of anecdotal evidence
-> Chondroitin sulphate and glucosamine
-> Hyaluronic Acid
-> Green lipped mussel
-> Boswellia
-> Devil’s claw – controlled substance under FEI
Biphosphonates - how do they work?
- DMOAD
- Osteoclast inhibitors – bind to osteoclasts which in turn
decreases osteoblast activity and bone turnover - Reduce rate of bone resorption
- Reduce bone pain
What evidence for use of Biphosphonates?
- Bone spavin
- Navicular dx
- Thoracolumbar pain
Duration fo action for biphosphonates?
Approx 6 months
Risks associated with biphosphonates?
Colic and renal tox
give examples of biphosphonates
- Tiludronate -> admin via saline infusion intravenously over 30 mins ; licensed for bone spavin
- Clodronate -> Admin IM over 3 sites; licensed for navicular dx
Describe used of Sodium hyaluronate (HA)
- Glycosaminoglycan
- Component of articular cartilage and synovial fluid
- Local anti-inflammatory effect and chondroprotective
How do we admin HA?
- Intravenous(40mg) Repeated weekly for 3 treatments
- SMOAD + DMOAD [Kawcak et al, 1997]or Intra-articular (20mg/joint)
- Flare rate of 12%
- Does not result in a substantial enough reduction in lameness when used alone
Best use of HA?
Acute/mild to moderate synovitis
describe polysulfated glycosaminoglycans?
Increase HA synthesis, stimulate cartilage matrix synthesis, decrease matrix
degradation
when are P O L Y S U L F A T E D G L Y C O S A M I N O G L Y C A N S used ?
- Most commonly used intramuscularly →
- Improves lameness and stride length [White et al, 1996]
- 7 treatments(500mg) every 4 days for 28 days
- Can be given intra-articularly
- Associated with higher incidence of joint sepsis
best use for polysulfated glycosaminoglycans?
synovitis